Dr Will West

Will West completed his Unilever-sponsored PhD in immunology/virology in 1992, going on to a post-doctoral position at the National Institute of Biological Standards and Control. From there, he joined Procter & Gamble Healthcare where he worked for nearly seven years, leading an international clinical development team. Having obtained an MBA from London Business School in 2001, he joined the biotech industry focusing on tissue engineering and cell-based therapeutics. He has worked and consulted for a number of companies including in the bone and neural regenerative space. He was subsequently approached by Avlar BioVentures to help initiate CellCentric, a start-up company focused on epigenetics and cell fate control. He was appointed CEO of CellCentric in November 2005.

Back to Our People